Stock ABUS ARBUTUS BIOPHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Arbutus Biopharma Corporation

Equities

ABUS

CA03879J1003

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
3.36 USD +1.20% Intraday chart for Arbutus Biopharma Corporation +2.13% +34.40%
May. 20 Whitefort Capital Management Sends an Open Letter to Shareholders of Arbutus Biopharma CI
May. 17 Sector Update: Health Care Stocks Mixed Late Afternoon MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Arbutus to Participate in Jefferies Global Healthcare Conference
GL
Arbutus to Present Imdusiran Data at EASL Congress 2024
AQ
Arbutus to Present Imdusiran Data at EASL Congress 2024
GL
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value
AQ
Whitefort Capital Management Sends an Open Letter to Shareholders of Arbutus Biopharma
CI
Sector Update: Health Care Stocks Mixed Late Afternoon
MT
Sector Update: Health Care Stocks Softer Friday Afternoon
MT
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program
MT
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program
MT
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value
BU
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders
CI
Investor Whitefort urges Arbutus Biopharma to halt stock sales, find partner
RE
Whitefort Capital Management Engages with Arbutus Biopharma
CI
Arbutus to Participate in Two Upcoming Investor Conferences
GL
Arbutus Biopharma : Corporate Presentation - May 2024
PU
Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024
Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M
MT
Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M, vs. Street Est of $3.7M
MT
Arbutus: Q1 Earnings Snapshot
AQ
Arbutus Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABUS Stock
  4. News Arbutus Biopharma Corporation